Triple Marker Test Explained: Normal Range, Report Reading, Risk for Down Syndrome & Birth Defects (India 2026) | ट्रिपल मार्कर टेस्ट गाइड
Triple Marker Test in Pregnancy Explained: Normal Range, High Risk Report & What to Do Next (India 2026)
ट्रिपल मार्कर टेस्ट: नॉर्मल रेंज, हाई रिस्क रिपोर्ट का मतलब और आगे क्या करें — पूरी गाइड
Your doctor has ordered a Triple Marker Test — and you may feel anxious about what it means, especially if the report says "High Risk." The Triple Marker Test is one of India's most commonly used second-trimester prenatal screening tests, ordered between 15 and 20 weeks of pregnancy. It screens for chromosomal abnormalities in the baby — particularly Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18), and neural tube defects like spina bifida. Understanding what the test actually measures — and crucially, what it does and does not mean — is essential before making any decisions.
This guide explains the Triple Marker Test in simple English and Hindi — the three hormones measured, how the risk is calculated, how to read a high-risk or low-risk result, why a high-risk result is not a diagnosis, and what confirmatory tests are available in India including NIPT and amniocentesis. For general lab report reading, see our beginner's guide to blood test reports.
ट्रिपल मार्कर टेस्ट गर्भावस्था के 15–20 सप्ताह के बीच एक स्क्रीनिंग टेस्ट है जो बच्चे में Down syndrome और neural tube defects जैसी असामान्यताओं की जांच करता है। यह गाइड इसे सरल अंग्रेजी और हिंदी में समझाती है। Table of Contents / विषय सूची
What Is the Triple Marker Test? / ट्रिपल मार्कर टेस्ट क्या है?
The Triple Marker Test (also called the Triple Screen, Maternal Serum Screening, or Second Trimester Screening) is a simple blood test drawn from the mother's arm — it does not involve the baby or the amniotic fluid. It measures three specific substances in the mother's blood whose levels are produced by the placenta and the foetus. Abnormal patterns in the combination of all three — taking into account the mother's age, gestational age, and weight — are associated with an increased statistical risk of certain chromosomal or structural conditions in the baby.
ट्रिपल मार्कर टेस्ट मां के रक्त में तीन विशिष्ट पदार्थों को मापता है जो प्लेसेंटा और भ्रूण द्वारा उत्पादित होते हैं। माँ की उम्र, गर्भकालीन आयु, और वजन को ध्यान में रखते हुए तीनों का असामान्य पैटर्न एक सांख्यिकीय जोखिम का संकेत देता है।The Three Hormones — AFP, hCG, and Estriol
Each of the three hormones is expressed as a MoM (Multiple of the Median) — a value that compares the patient's level to the median level expected for a normal pregnancy at that exact gestational age. A MoM of 1.0 means exactly average; 0.5 means half the average; 2.0 means twice the average. The software combines all three MoM values with maternal age, gestational age, and weight to calculate the final risk ratio.
प्रत्येक हार्मोन को MoM (Multiple of the Median) के रूप में व्यक्त किया जाता है — रोगी का स्तर उस सटीक गर्भकालीन आयु पर अपेक्षित सामान्य मध्यमान स्तर से तुलना करता है।AFP is a protein produced by the foetal liver and yolk sac. In a normal pregnancy, AFP levels in the mother's blood increase gradually from 15 to 20 weeks. Low AFP (below 0.5 MoM) is associated with Down syndrome and Edwards syndrome. High AFP (above 2.5 MoM) is associated with neural tube defects (open spina bifida, anencephaly), abdominal wall defects, multiple pregnancies, and underestimated gestational age. AFP measurement timing is extremely sensitive to gestational age — even one week difference significantly changes the expected value.
hCG is the "pregnancy hormone" produced by the placenta. In normal pregnancy, it peaks in the first trimester and falls by 15–20 weeks. In Down syndrome pregnancies, the placenta produces abnormally high hCG in the second trimester — often above 2.0–2.5 MoM. In Edwards syndrome (Trisomy 18), hCG is abnormally low (below 0.5 MoM) — part of the "triple low" pattern. High hCG alone (without other marker abnormalities) can also result from multiple pregnancy or recent molar pregnancy.
uE3 is a form of oestrogen produced jointly by the foetal adrenal glands, foetal liver, and placenta — requiring all three to function normally. Low uE3 (below 0.5–0.7 MoM) is seen in Down syndrome and Edwards syndrome — because foetal liver and adrenal function are impaired in these conditions. Very low or undetectable uE3 may also indicate a rare condition called Smith-Lemli-Opitz syndrome. uE3 is the most variable of the three markers and is most sensitive to errors in gestational age dating.
Absolute values of AFP, hCG, and uE3 change significantly with gestational age — they are meaningless without comparison to the expected value at that exact week. MoM standardises the comparison. This is also why an accurate gestational age — confirmed by ultrasound measurement, not just last menstrual period (LMP) — is the most critical input for a reliable Triple Marker result. An error of even one week in gestational age can shift the MoM values significantly, changing the final risk calculation.
Reading Your Triple Marker Report — Risk Ratios Explained
The final output of the Triple Marker Test is not a simple "positive" or "negative" — it is a risk ratio expressed as a fraction (e.g., 1 in 100, 1 in 500, 1 in 5000) for each condition screened. This ratio represents the statistical probability that the foetus has that condition, based on all three hormone levels combined with the mother's age and gestational age.
ट्रिपल मार्कर टेस्ट का अंतिम आउटपुट एक जोखिम अनुपात है जो एक अंश के रूप में व्यक्त किया जाता है (जैसे 1 में 100, 1 में 500)।| Condition | Low Risk / Normal | High Risk Threshold (most labs) | AFP | hCG | uE3 pattern |
|---|---|---|---|
| Down Syndrome (Trisomy 21) डाउन सिंड्रोम |
1 in 250 or lower risk | 1 in 250 or higher risk | Low AFP ↓ · High hCG ↑ · Low uE3 ↓ |
| Edwards Syndrome (Trisomy 18) एडवर्ड्स सिंड्रोम |
1 in 100 or lower risk | 1 in 100 or higher risk | Low AFP ↓ · Low hCG ↓ · Low uE3 ↓ (triple low) |
| Neural Tube Defects (NTD) न्यूरल ट्यूब दोष / स्पाइना बिफिडा |
AFP MoM below 2.5 | AFP MoM above 2.5 | High AFP ↑ · Normal hCG · Normal uE3 |
High Risk Result — What It Means and What to Do Next
Receiving a "High Risk" Triple Marker result is one of the most anxiety-inducing moments in a pregnancy — and it is important to respond with information rather than panic. The key clinical facts to hold onto:
"हाई रिस्क" ट्रिपल मार्कर परिणाम प्राप्त करना गर्भावस्था के सबसे चिंताजनक क्षणों में से एक है — सूचना के साथ जवाब देना महत्वपूर्ण है, घबराहट के साथ नहीं।The Triple Marker Test has a 5% false positive rate — meaning 1 in 20 healthy, normal pregnancies will generate a high-risk result. For a common cut-off of 1 in 250, the positive predictive value (actual probability that the baby is affected when the test is high risk) is only about 3–5% — meaning over 95% of "high risk" Triple Marker pregnancies deliver chromosomally normal babies. This is inherent to the test's design as a population screen.
Incorrect gestational age (the most common cause — even 1 week error shifts MoM values significantly), multiple pregnancy (twins dramatically raise AFP and hCG), maternal diabetes (lower AFP), incorrect maternal weight entry, and sample handling errors. This is why an ultrasound for gestational age confirmation is always done alongside or before the Triple Marker — an inaccurate gestational age makes the entire result unreliable.
Consult a Maternal-Foetal Medicine Specialist (MFM) or a trained gynaecologist — do not act on the report alone without specialist counselling. A detailed Level II Anomaly Scan (Targeted Imaging for Foetal Anomalies — TIFFA scan) at 18–20 weeks should be done to look for structural markers of Down syndrome (nuchal fold thickness, nasal bone, cardiac defects). NIPT (Non-Invasive Prenatal Testing) is the recommended next step for most families — a highly accurate blood test that analyses foetal DNA in the mother's blood.
Before proceeding to amniocentesis or CVS (which carry a small risk of miscarriage), genetic counselling is strongly recommended. A genetic counsellor explains the actual probability in the context of the specific result, discusses the implications of each confirmatory option, and supports the family in making an informed decision. Many government hospitals and referral centres in India now have genetic counselling services — do not proceed to invasive testing without this step.
Conditions the Triple Marker Screens For
The most common chromosomal abnormality screened — caused by an extra copy of chromosome 21. Affects approximately 1 in 700–1000 births globally, with risk rising significantly with maternal age (risk at 35 is ~1 in 250; at 40 is ~1 in 60; at 45 is ~1 in 20). Features: intellectual disability, characteristic facial features, heart defects (40–50%), and increased risk of leukaemia and thyroid disease. People with Down syndrome can lead meaningful, fulfilling lives — genetic counselling helps families understand the spectrum.
Caused by an extra copy of chromosome 18. Much less common than Down syndrome (~1 in 5000 live births) but associated with severe multiple organ malformations. Most affected pregnancies result in miscarriage or stillbirth. Infants born alive typically have a very short life expectancy — though long-term survivors exist with intensive support. The "triple low" pattern (all three markers below median) on Triple Marker is the classic signal.
Open neural tube defects — spina bifida (incomplete spine closure) and anencephaly (incomplete brain formation) — are detected by high AFP in the mother's blood because the foetal protein leaks through the open defect into the amniotic fluid and then into the mother's circulation. India has one of the world's highest NTD rates, strongly linked to widespread folate deficiency. These defects are almost entirely preventable by adequate folic acid supplementation before and during early pregnancy. A level II ultrasound confirms the diagnosis when AFP is elevated.
Triple Marker does not screen for: structural heart defects, cleft lip/palate, limb abnormalities, most genetic syndromes (Turner, Patau), single-gene disorders (cystic fibrosis, sickle cell, thalassaemia), or any condition that does not affect these three hormone levels. A normal Triple Marker does not mean the baby has no structural or genetic abnormality — a comprehensive anomaly scan and targeted testing based on family history are complementary.
Confirmatory Tests — NIPT, Amniocentesis & CVS
| Test | Accuracy | When done | Risk | Best for |
|---|---|---|---|---|
| Triple Marker | 70–75% for Down syndrome | 15–20 weeks | None (blood test) | Initial population-level screening — inexpensive, widely available |
| NIPT (Non-Invasive Prenatal Testing) | > 99% for Trisomy 21, 18, 13 | 10 weeks onwards | None (blood test) | Highly accurate non-invasive screening after high-risk Triple Marker. Cannot confirm — requires invasive testing if positive |
| Amniocentesis | 99.9% — definitive diagnosis | 15–20 weeks | 0.1–0.5% miscarriage risk | Definitive chromosomal diagnosis. Recommended after high-risk NIPT or very high-risk Triple Marker |
| CVS (Chorionic Villus Sampling) | 99.9% — definitive diagnosis | 10–13 weeks | 0.5–1% miscarriage risk | Definitive diagnosis in first trimester. Same accuracy as amniocentesis with slightly higher procedure risk |
| Level II / TIFFA Anomaly Scan | High for structural defects | 18–20 weeks | None (ultrasound) | Structural markers of Down syndrome (nuchal fold, nasal bone, heart defects). Complements Triple Marker and NIPT |
✅ Book Triple Marker Test — Home Collection Available
The Triple Marker Test must be done between 15–20 weeks of pregnancy. Accurate gestational age dating by ultrasound before the test is essential for a reliable result. Home collection is available in most Indian cities:
Affiliate link: I may earn a small commission at no extra cost to you. Prices as of April 2026. Always confirm gestational age by ultrasound before booking. Home collection available in most Indian cities. If your result is high risk, do not act on the report alone — consult your gynaecologist or MFM specialist first.
ट्रिपल मार्कर टेस्ट 15–20 सप्ताह की गर्भावस्था में होना चाहिए। टेस्ट से पहले अल्ट्रासाउंड द्वारा सटीक गर्भकालीन आयु पुष्टि आवश्यक है। Pregnancy Support Products — Comfort & Nutrition During Second Trimester
COOZLY G Shape Belly & Back Maternity Pregnancy Pillow
By 15–20 weeks (when Triple Marker is done), many women experience back pain, hip discomfort, and difficulty sleeping. A specially designed pregnancy pillow supports the belly, back, and hips simultaneously — helping maintain side-sleeping position recommended for foetal circulation in the second and third trimesters. Not a medical device — for comfort and sleep support only.
View on Amazon India
Carbamide Forte Multivitamin for Women — 43 Ingredients (60 Tablets)
Comprehensive women's multivitamin with folic acid, iron, calcium, Vitamin D, B12, and 43 micronutrients. Adequate folic acid is particularly critical during pregnancy — Indian women have high rates of folate and B12 deficiency, both of which affect the Triple Marker result and foetal development. Always consult your gynaecologist before starting any supplement during pregnancy — dosage and composition should match your specific antenatal requirements.
View on Amazon IndiaDisclosure: These are affiliate links. We may earn a small commission at no extra cost to you. These products are for general support and are not a substitute for prescribed antenatal medications or medical advice.
Related Tests / संबंधित जांचें
These tests are commonly ordered alongside or after the Triple Marker during pregnancy in India:
भारत में गर्भावस्था के दौरान ट्रिपल मार्कर के साथ या बाद में ये जांचें अक्सर करवाई जाती हैं:Frequently Asked Questions / अक्सर पूछे जाने वाले सवाल
A "High Risk" result means the statistical probability that the foetus has Down syndrome (or Trisomy 18 or a neural tube defect) is higher than the age-adjusted cut-off — typically 1 in 250 for Down syndrome in most Indian labs. It does NOT mean the baby definitely has a chromosomal abnormality. In fact, because the Triple Marker has a 5% false positive rate, over 95% of high-risk results come from perfectly normal pregnancies. The most critical next step is to consult your gynaecologist or a Maternal-Foetal Medicine specialist — not to panic, and not to make any irreversible decision. A Level II anomaly scan and NIPT (or amniocentesis) will give a far more accurate picture.
उत्तर: "हाई रिस्क" का मतलब है कि सांख्यिकीय संभावना कट-ऑफ से अधिक है — लेकिन 95%+ हाई रिस्क परिणाम पूरी तरह से सामान्य गर्भावस्थाओं से आते हैं। अगला कदम: स्त्री रोग विशेषज्ञ से परामर्श, Level II स्कैन, और NIPT।No — a low-risk result is reassuring but not a guarantee. The Triple Marker has only 70–75% sensitivity for Down syndrome — meaning it misses approximately 25–30% of Down syndrome pregnancies, which come back as "Low Risk." A low-risk result means the statistical probability is below the cut-off for the mother's age, which is genuinely reassuring for most pregnancies. However, no screening test can guarantee a completely normal baby. A comprehensive Level II anomaly scan at 18–20 weeks remains important regardless of the Triple Marker result — it checks for structural abnormalities that the Triple Marker cannot detect.
उत्तर: नहीं — लो रिस्क आश्वस्त करने वाला है लेकिन गारंटी नहीं। ट्रिपल मार्कर 25–30% Down syndrome मामले चूक जाता है। 18–20 सप्ताह पर Level II एनोमली स्कैन परिणाम की परवाह किए बिना महत्वपूर्ण है।The Triple Marker Test is valid only between 15 and 20 weeks of pregnancy — most accurately between 16 and 18 weeks. Before 15 weeks, the hormone levels are not yet at the values the risk calculation is calibrated for. After 20 weeks, the window closes and the test is no longer interpretable. The gestational age must be confirmed by ultrasound (not just last menstrual period/LMP) before the test — an error of even one week significantly affects the MoM calculations and can falsely shift the risk. If you are unsure of your exact gestational age, get an ultrasound first, then proceed to the Triple Marker.
उत्तर: ट्रिपल मार्कर टेस्ट 15–20 सप्ताह की गर्भावस्था में वैध है, सबसे सटीक 16–18 सप्ताह में। गर्भकालीन आयु अल्ट्रासाउंड द्वारा पुष्टि होनी चाहिए — LMP से नहीं।No — fasting is not required for the Triple Marker Test. The hormone levels measured (AFP, hCG, uE3) are not significantly affected by food intake. You can eat and drink normally before giving the blood sample. The test can be done at any time of day. The most important preparation is having an accurate gestational age dating by ultrasound — not the timing of your last meal. If the Triple Marker is being ordered alongside other antenatal tests that require fasting (such as fasting blood sugar or oral glucose tolerance test), follow those fasting instructions; the Triple Marker itself needs no preparation.
उत्तर: नहीं — ट्रिपल मार्कर टेस्ट के लिए उपवास आवश्यक नहीं है। आप सामान्य रूप से खाने-पीने के बाद सैंपल दे सकती हैं। सबसे महत्वपूर्ण तैयारी: अल्ट्रासाउंड द्वारा सटीक गर्भकालीन आयु पुष्टि।These are all prenatal serum screening tests that measure different combinations of markers. The Double Marker Test (also called First Trimester Combined Screening) is done at 11–14 weeks — it measures PAPP-A (Pregnancy-Associated Plasma Protein A) and free beta-hCG alongside a nuchal translucency ultrasound measurement. It has slightly better detection rates than the Triple Marker for Down syndrome (85–90%) and is increasingly preferred in India for women presenting early in pregnancy. The Triple Marker (AFP + hCG + uE3) is the standard second trimester option (15–20 weeks). The Quadruple Marker adds Inhibin-A to the Triple Marker, improving Down syndrome detection to approximately 80–85%. All are screening tests — none is diagnostic. NIPT outperforms all of them in accuracy while remaining non-invasive.
उत्तर: डबल मार्कर (PAPP-A + free beta-hCG + NT ultrasound, 11–14 सप्ताह, 85-90% सटीकता) पहली तिमाही के लिए। ट्रिपल मार्कर (AFP + hCG + uE3, 15–20 सप्ताह) दूसरी तिमाही के लिए। क्वाड्रपल मार्कर ट्रिपल + Inhibin-A। NIPT सभी की तुलना में अधिक सटीक।The Triple Marker is recommended for all pregnant women but is especially important for: women above 35 years of age (risk of Down syndrome rises sharply after 35), women with a personal or family history of chromosomal abnormalities, women with a previous child with Down syndrome or other chromosomal conditions, women who had abnormal first trimester screening (Double Marker or NT ultrasound), and pregnancies conceived through IVF or other assisted reproduction. In India, with the wide availability of the test and its relatively low cost, most obstetricians recommend it as part of the standard second-trimester antenatal panel for all women — regardless of age. However, it is ultimately the woman's and family's choice whether to undergo prenatal screening, based on informed counselling.
उत्तर: ट्रिपल मार्कर सभी गर्भवती महिलाओं के लिए अनुशंसित है, लेकिन विशेष रूप से 35 वर्ष से ऊपर, chromosomal असामान्यताओं का पारिवारिक इतिहास, पिछले असामान्य स्क्रीनिंग, और IVF गर्भावस्थाओं के लिए।- MedlinePlus (NIH): Triple Screen Test — Patient Information
- ACOG (American College of Obstetricians and Gynaecologists): Prenatal genetic screening and testing guidelines.
- FOGSI (Federation of Obstetric and Gynaecological Societies of India): Guidelines for prenatal screening in Indian pregnancies.
⚠️ Medical Disclaimer / चिकित्सा अस्वीकरण
This article is for educational purposes only. Triple Marker results must always be interpreted by a qualified gynaecologist or Maternal-Foetal Medicine specialist in the context of the complete antenatal assessment — gestational age, maternal age, ultrasound findings, and family history. A "High Risk" result is not a diagnosis and must never lead to an irreversible decision without confirmatory testing and genetic counselling. This guide does not replace individualised medical advice from your treating obstetrician.
यह लेख केवल शैक्षिक उद्देश्यों के लिए है। ट्रिपल मार्कर परिणाम हमेशा एक योग्य स्त्री रोग विशेषज्ञ द्वारा व्याख्या किए जाने चाहिए। "हाई रिस्क" परिणाम पुष्टि परीक्षण और आनुवंशिक परामर्श के बिना किसी भी अपरिवर्तनीय निर्णय का आधार नहीं होना चाहिए।
Comments
Post a Comment